Drug Trial Radar · NCT02910206
Etomidate to Improve Outcome in Elderly Patients
Last checked: Nov 19, 2026Latest source record: Dec 10, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,917
Actual
Start
Aug 15, 2017
Primary completion
Nov 20, 2019
Study completion Nov 20, 2020
Sponsor
- Lead sponsor
- Zhihong LUAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 21, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Elderly patients have high mortality and postoperative complications rate after surgery, especially postoperative cardiac complications. A meta-analysis revealed haemodynamic intraoperative events significantly increased the risk of postoperative cardiac complications.To limit the risk, optimize the intraoperative management of circulation is essential. Anesthetic drug may effect on the haemodynamic intraoperative, reduction of postoperative complications should aimed at choosing the optimal anesthetic drug with minimal effect on haemodynamic.So this study is to explore the comparative efficacy and safety of anesthetic drug (etomidate or propofol) in elderly patients
Conditions
- Postoperative Complications
Interventions
EtomidateDrug
etomidate is given intravenously
propofolDrug
propofol is given intravenously
SufentanilDrug
sufentanil is given intravenously
CisatracuriumDrug
Cisatracurium is given intravenously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with complications defined by ICD (International codes of diseases)-9Time frame: From the moment of giving sufentanil to the moment of discharge from hospital,up to 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Xijing Hospital, Fourth Military Medical University
Xi'an, Shaanxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.